IL33 and lung cancer: Their research findings further indicated that the interaction between IL-33 and ST2 could up-regulate the level of glucose transporter type 1 (GLUT1) in the cell membrane, thereby enhancing the glucose uptake and glycolysis of lung cancer cells, and providing optimal energy support for the malignant growth of lung cancer cells.